POINT Biomedical
Pharmaceutical company developing technologies for imaging and drug deliveries.
Launch date
Employees
Market cap
-
Enterprise valuation
€16—23m (Dealroom.co estimates Jul 2007.)
San Carlos California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $1.8m | Series E | |
| N/A | $27.0m | Series F | |
| N/A | $4.3m | Series G | |
$25.0m | Growth Equity VC | ||
| Total Funding | €52.8m | ||
Related Content
Recent News about POINT Biomedical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.